Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G
نویسندگان
چکیده
منابع مشابه
Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G.
BACKGROUND Gomisin G, isolated from herb Schisandra chinensis, exhibits anti-tumor activities. Therefore, Gomisin G is a drug candidate for anti-liver cancer therapy. AIMS To predict the metabolic behavior and metabolism-based drug-drug interaction of gomisin G. METHODS Molecular docking method was used. The crystal structure of CYP3A4 with the ligand ketoconazole was chosen from protein da...
متن کاملDrug-drug interaction study of ketoconazole and ritonavir-boosted saquinavir.
Saquinavir, a potent human immunodeficiency virus protease inhibitor, is extensively metabolized by CYP3A4. Saquinavir is coadministered with ritonavir, a strong CYP3A4 inhibitor, to boost its exposure. Ketoconazole is a potent CYP3A inhibitor. The objectives of this study were to investigate the effect of ketoconazole on the pharmacokinetics of saquinavir/ritonavir and vice versa using the app...
متن کاملEdoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine
AIMS Edoxaban, a novel factor Xa inhibitor, is a substrate of cytochrome P450 3 A4 (CYP3A4) and the efflux transporter P-glycoprotein (P-gp). Three edoxaban drug-drug interaction studies examined the effects of P-gp inhibitors with varying degrees of CYP3A4 inhibition. METHODS In each study, healthy subjects received a single oral dose of 60 mg edoxaban with or without an oral dual P-gp/CYP3A...
متن کاملDrug-drug interaction prediction assessment.
Model-based drug-drug interaction (DDI) is an important in-silico tool to assess the in vivo consequences of in vitro DDI. Before its general application to new drug compounds, the DDI model is always established from known interaction data. For the first time, tests for difference and equivalent tests are implemented to compare reported and model-base simulated DDI (log AUCR) in the sample mea...
متن کاملDeepSynergy: Prediction of anti-cancer drug synergies with Deep Learning
Kristina Preuer , Richard P.I. Lewis , Sepp Hochreiter , Andreas Bender , Krishna C. Bulusu 2,3 and Günter Klambauer 1 1Institute of Bioinformatics, JKU, Altenberger Str. 69, 4040 Linz, Austria 2Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK 3 AstraZeneca, Oncology Innovative Medicines and Early Development, Astr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: African Health Sciences
سال: 2015
ISSN: 1680-6905
DOI: 10.4314/ahs.v15i2.35